As of 2026-01-05, the Intrinsic Value of Abivax SA (ABVX.PA) is -14.69 EUR. This ABVX.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 115.00 EUR, the upside of Abivax SA is -112.78%.
Based on its market price of 115.00 EUR and our intrinsic valuation, Abivax SA (ABVX.PA) is overvalued by 112.78%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -14.69 - -14.69 | -14.69 | -112.78% |
| P/E | (9.23) - (18.40) | (13.81) | -112.0% |
| DDM - Stable | (27.85) - (147.59) | (87.72) | -176.3% |
| DDM - Multi | (19.04) - (81.46) | (31.21) | -127.1% |
| Market Cap (mil) | 8,961.95 |
| Beta | 0.91 |
| Outstanding shares (mil) | 77.93 |
| Enterprise Value (mil) | 8,951.37 |
| Market risk premium | 5.82% |
| Cost of Equity | 8.59% |
| Cost of Debt | 5.00% |
| WACC | 8.55% |